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Abstract 
 
PURPOSE: Central line associated blood stream infections pose a threat to patient safety and are 
costly to healthcare systems. Heath care professional frequently access central venous access 
device (CVAD) to obtain blood samples for laboratory analysis. A commonly accepted 
procedure practice involves exchanging 3-4 syringes during the collection process. Each time a 
syringe is exchanged during the lab collection process the opportunity for bacteria to be 
introduced into the bloodstream exists. Decreasing the number of times a CVAD is accessed 
removes opportunities for bacteria to be introduced to the line thus decreasing the risk of 
infection. Due to the occurrence of CLABSI on a pediatric hematology/oncology (hemonc) unit, 
a practice change employing the use of stopcocks to reduce the frequency of direct access to the 
CVAD was implemented in 2013. The purpose of this project was to evaluate the stopcock 
method practice used for lab collections from CVAD among children on a pediatric hemonc unit. 
The goal of this evaluation is to determine if the implementation of the stopcock reduced 
CLABSI rates.  
 
METHODS: A retrospective pre/post implementation design was used to evaluate the use of the 
stopcock method for lab collection. The data analysis involved comparing infections rates prior 
to implementation of the stopcock method to infection rates collected after its implementation. 
This project design is quantitative in nature as infection rates were compiled for comparison and 
analysis. 
 
RESULTS: Monthly unit CLABSI rates were reviewed for patients admitted over a 10-year span 
(2008-2018). The data showed an increase in overall CLABSI rates after the initiation of the 
	  
	   ii	  
stopcock. The infection rates prior to the initiation of stopcocks ranges from 26.7-41 with an 
average of 31.4 for the 5 pre-years assessed versus 35.7-52.9 with an average of 43.2 for the 6 
post-years assessed.  
 
CONCLUSION: The 10-year data review revealed CLABSI rates increased on the hemonc unit 
after the introduction of the stopcock apparatus use for lab collection. However, this study 
uncovered a number of confounding variables such as the lack of a standardized practice 
protocol. These confounding variables limit the conclusiveness of the study findings. Further 
research is recommended in order to determine the best practice for lab collections from CVADs.    
 
 
 
 
 
 
 
 
	   1	  
Acknowledgments 
Leslie Scott, PhD, APRN, CDE, MLDE—Committee Chair 
 
Nicole Garritano, DNP, RN—Committee Member 
Chris Donaghey, MSN, RN, PCNS-BC, CPN, CPHON - Committee Member/Clinical Mentor 
 
 
First, I owe my sincerest thank you to Dr. Leslie Scott. Without whom I would have never 
survived this project or program. Thank you for all of the time you spent answering my questions 
and tending to my type A personality. You have been kind and encouraging when I was stressed 
and overwhelmed. You played an instrumental role in the development of this DNP project and I 
cannot begin to thank you enough for all of your help.  
 Dr. Nicole Garritano, thank you for your guidance and encouragement through various 
courses throughout this program. Thank you for your assistance and advice on my final project.  
Finally, Chris Donaghey, thank you for saying yes to assisting with this project. My DNP 
project was all extra work for you and I sincerely appreciate all of your time and guidance that 
you so willingly gave to a perfect stranger. 
 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	   2	  
Dedication 
 I would like to dedicate this manuscript to my parents and my sister for all of their love 
and support over the past 8 years of my education journey. My family has pushed me and 
cheered me on through the years and I am eternally grateful. I would also like to dedicate my 
DNP project to my fiancé, Christian Bowling. Without your support and endless encouragement 
through this process I would never have made it. I look forward to all of the homework-free 
weekends in our future. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
	   3	  
Table of Contents 
ACKNOWLEDGMENTS ............................................................................................................. 1 
DEDICATION ............................................................................................................................... 2 
BACKGROUND AND PROBLEM STATEMENT ................................................................... 5 
Context of the Problem ................................................................................................................................................ 5 
Consequences of the Problem ...................................................................................................................................... 6 
Evidenced-based Intervention ..................................................................................................................................... 6 
Purpose of the Project .................................................................................................................................................. 7 
THEORETICAL FRAMEWORK/PROCESS IMPROVEMENT MODEL ........................... 8 
REVIEW OF LITERATURE ...................................................................................................... 8 
Stopcock Use ................................................................................................................................................................. 9 
Infection Potential ........................................................................................................................................................ 9 
Potential Benefits of Stopcocks ................................................................................................................................. 10 
AGENCY DESCRIPTION ......................................................................................................... 11 
Setting and Population ............................................................................................................................................... 11 
Congruence with Organizational Mission ................................................................................................................ 12 
Description of Stakeholders ....................................................................................................................................... 12 
Site-specific Facilitators and Barriers ...................................................................................................................... 13 
PROJECT DESIGNS AND METHODS ................................................................................... 14 
Description of Intervention ....................................................................................................................................... 14 
IRB Approval .............................................................................................................................................................. 14 
Sample ......................................................................................................................................................................... 15 
Data Analysis and Measures ..................................................................................................................................... 15 
Implementation ........................................................................................................................................................... 16 
TIMELINE, RESOURCES, AND FEASIBILITY ................................................................... 17 
	  
	   4	  
Timeline ....................................................................................................................................................................... 17 
Sustainability .............................................................................................................................................................. 17 
RESULTS ..................................................................................................................................... 18 
DISCUSSION ............................................................................................................................... 19 
LIMITATIONS ............................................................................................................................ 21 
Biopatch ....................................................................................................................................................................... 21 
Chlorhexidine-gluconate Cleanse ............................................................................................................................. 22 
Needleless Cap Maintenance ..................................................................................................................................... 22 
Stopcock Apparatus Assembly .................................................................................................................................. 22 
Practice Protocol ........................................................................................................................................................ 23 
FUTURE IMPLICATIONS ....................................................................................................... 23 
SUMMARY/CONCLUSION ...................................................................................................... 24 
REFERENCES ............................................................................................................................ 25 
FIGURE 1: STOPCOCK APPARATUS ................................................................................... 28 
FIGURE 2: THE ADOPTION PROCESS ................................................................................ 29 
APPENDIX A: STOPCOCK METHOD INTERVENTION .................................................. 30 
TABLE 1: OVERALL CLABSI RATES PER 1000 LINE DAYS .......................................... 31 
TABLE 2: UNIT TOTAL CLABSI RATES ............................................................................. 32 
TABLE 3: HEMATOLOGY/ONCOLOGY CLABSI RATES BY AREA ............................ 33 
TABLE 4: HEMATOLOGY/ONCOLOGY CLABSI RATES BY AREA ............................ 34 
  
 
 
 
	  
	   5	  
Evaluating the use of Stopcocks for Lab Collections from Central Venous Access Devices 
Related to Central Line Associated Blood Stream Infections 
 
Background and Problem Statement 
 Central-line associated blood stream infections (CLABSI) are associated with thousands 
of deaths and billions of dollars in added expenses annually (Center for Disease Control and 
Prevention, 2016). A central line associated blood stream infection is acquired when germs enter 
the bloodstream through the central line. These preventable infections are not only costly for the 
healthcare system but also incredibly dangerous for patients. A study by Wilson, Rafferty, 
Deeter, Comito, & Hollenbeak (2014, p 575) found, "among pediatric hematology/oncology 
patients, CLABSI is associated with an increased LOS of 13.3 days and increased costs of 
$37,385 concluding that eliminating CLABSIs reduced the total cost of admission in by 35%". 
There are factors that contribute an individual patient's susceptibility but essentially these 
infections happen due to operator error. Failure to maintain a sterile field or aseptic technique 
during placement or maintenance of a central line is classified as operator error (Shah, Bosch, 
Thompson, & Hellinger, 2013). 
Context of the Problem 
 CVAD are useful in the acute care setting and are often used for medication, 
administering parenteral fluids and nutrition, or collecting blood samples for laboratory analysis 
(Center for Disease Control and Prevention, 2010). Healthcare professionals access CVADs in 
order to obtain the sample for laboratory analysis. Collecting blood off of a central line provides 
a significant opportunity for contamination. Current practice guidelines that are preformed in 
most hospital settings involve multiple exchanges of the syringe that is attached to the central 
line. A commonly accepted procedure practice for accessing central lines includes the use of 
three to four of syringes during the lab collection process (Day, 2018). After every syringe 
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exchange the operator is instructed to disinfect the catheter hub (Day, 2018). Each time the 
syringe is exchanged and a new syringe is connected the opportunity for bacteria to be 
introduced is presented. The risk for infection is especially high if the hub is not properly 
disinfected between every syringe exchange. Decreasing the number of times a central line is 
accessed could result in a decrease in the risk of acquiring a CLABSI.   
Consequences of the Problem 
 The significance of a central line infection is that it is a preventable condition that is 
costly for hospitals and potentially fatal for patients. Central line infections over the past 10 years 
have been estimated to occur about 250,000 times a year in the United States (Center for Disease 
Control and Prevention, 2016). The medical community has given this problem attention and has 
worked to develop practice changes and protocols in an attempt eradicate its occurrence. While 
this number has been on the decline there is still significant room for improvement of this costly 
problem. A study conducted on a pediatric hematology/oncology unit by Wilson, Rafferty, 
Deeter, Comito, & Hollenbeak (2014) found for this population "a central line associate blood 
stream infection increases health care costs by nearly $70,000 and increases the length of stay by 
nearly 3 weeks". Riley Hospital for Children had seen a steady decline in CLABSI rates, which 
started in 2008. In 2012 there was a major spike in CLABSI rates, which prompted practice 
changes including the stopcock method in 2013. Stopcock use for lab collections from CVAD 
could provide an additional method of CVAD care that attempts to decrease CLABSI rates. 
Evidenced-based Intervention  
 The practice being evaluated includes the use of a set of stopcocks (Figure 1) for lab 
collections from CVADs. Implementation of a stopcock method for lab collections should follow 
a comprehensive approach model involving setting a goal, identifying alternatives, implanting 
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programs, and monitoring results (Issel, 2018). The goal of this practice is to decrease the risk 
and occurrence of CLABSI through the use of a stopcock for all lab collections from central 
lines. There are numerous alternatives to this method for lab collections. However, other 
methods require the exchange of syringes resulting in multiple accesses per lab collection. 
Therefore, this practice is most appropriate in order to attempt to decrease the number of 
CLABSIs by decreasing number of times a line is accessed. There are also alternative 
explanations for a decrease in CLABSI rates such as sterilizing the catheter prior to access, the 
patient's immunity and uncontrollable condition, regular dressing changes, regular line changes, 
and other maintenance practices for the central line. Ideally, all central lines will be treated the 
same as the healthcare professionals handling them will follow the same protocols for care. The 
use of stopcocks for lab collections has been implemented in the hematology/oncology unit at 
Riley Hospital for Children along with central line bundling protocols. This unit has seen a 
fluctuation in CLABSI rates since the initiation of the stopcock method. The goal is to evaluate 
the stopcock method and current practices on the hematology/oncology unit. The data from prior 
to the initiation of the stopcock practice and after the initiation will be compared in a pre/post 
design. The expected outcome for use of stopcocks for collecting labs is that it will decrease the 
number of times a central line is accessed subsequently decreasing the risk of infection.  
Purpose of the Project 
 The purpose of this project is to evaluate the use of a double stopcock apparatus for lab 
collections from central lines. The goal is to provide data about the relationship between 
CLABSI rates and the implementation of stopcocks for lab collections. This project aims to 
evaluate CLABSI rates in a pre/post design in order to assess the degree to which the 
employment of stopcocks for lab collections assists in CLABSI rate reduction. If the data shows 
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that the use of stopcocks for lab collections and the CLABSI rates reduction are inversely related 
then the stopcock use will be initiated in other units of the hospital. However, if the data 
demonstrates an increase in CLABSI rates with the use of the stopcock lab collection method 
then the method will be further evaluated and potentially discontinued.   
Theoretical framework/process improvement model 
 The motivating theoretical framework used for this research is the adoption process, 
which is a conceptual framework (Botha & Atkins, 2005). The stopcock method is under 
evaluation to determine if it is a practice that should be continued and adopted by other areas of 
the hospital or rejected and discontinued by the hemonc unit. The pre/post design of this study 
will allude to the appropriate response for the adoption process. According to Botha & Atkins 
(2005) the adoption process involved the steps of ignorance, becoming aware, gaining interest, 
comparing alternatives, testing, and adopting or rejecting an intervention (Figure 2). The 
development of this study has followed this process and will conclude with the adoption or 
rejection of the stopcock intervention.  
Review of Literature 
 Evidence on the most appropriate way to collect blood for analysis from a central line the 
data is limited. However, data collectively suggests that CLABSIs are dangerous problem in 
healthcare that should be eliminated (Edwards et al., 2015).  According to the Center for Disease 
Control and Prevention (CDC), "Central-line associated blood stream infections result in 
thousands of deaths each year and billions of dollars in added costs to the U.S. healthcare 
system" (Center for Disease Control and Prevention, 2016). The guidelines from the CDC state, 
"the goal of an effective prevention program should be the elimination of catheter related blood 
stream infections from all patient-care areas" (O'Grady et al., 2017).  
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Stopcock Use 
 A stopcock is a device with valve that can be turned "on" and "off", which is used to 
control the flow through the line in which it is attached. Typically, stopcocks are used in one of 
two ways. The first, is adding a stopcock to an existing IV tubing line. This stopcock is generally 
used continuously for the life of the IV line. The second way in which a stopcock can be used is 
for an isolated, single use lab collection. In this context two stopcocks would be attached 
together to form a double stopcock, which provides four access ports for use. The use of a pair of 
stopcocks for a lab collection is a new practice with minimal data comparing it to traditional lab 
collection methods (Benedict, Mayer, & Craven, 2017). The Guidelines for The Prevention of 
Intravascular Catheter-Related Infections developed by the CDC state that stopcocks could be 
dangerous and should be capped when not being used (O'Grady et al., 2017). The guidelines do 
not specify the effectiveness of stopcocks being used solely for a lab collection and then 
discarded. However, the guidelines recommend minimizing the number of entries into the system 
and the single use of a set of stopcocks for lab collections would accomplish the CDC 
recommendations. Similarly, Edwards (2015) gives inconclusive recommendations regarding 
stopcock use and lab collections stating, "blood sampling from CVADs and arterial catheters 
may employ stopcocks".  
Infection Potential  
 There is significant evidence against continuous stopcock use as an add-on device to an 
IV fluid line due to its increased risk for infection (Infusion Nurses Society, 2011). The 
continuous use of a stopcock for tasks such as infusions and medication administration has been 
shown to have the potential to facilitate bacteria entry into the blood stream (O'Grady et al., 
2017). Oto, Imanaka, Konno, Nakataki, and Nishimura (2011) conducted a study that compared 
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needleless access devices protected by sterilizing caps and also found increase risks with the use 
of stopcocks in this facet. The study by Loftus et al. (2008) went even further to conclude 
stopcocks contaminate patients stating, "multidrug-resistant bacterial organisms are transmitted 
during the practice of general anesthesia to the intravenous stopcock sets". Finally, a randomized 
clinical trial conducted by Casey et al. (2003) concluded that contamination rates were much 
lower related to use of a single needleless connector than use of a three-way stopcock. 
 In contrast, Esteve et al. (2007) conducted a randomized trial in an ICU setting and found 
no significant difference in the infection rates when a stopcock is used versus when a needleless 
valve connector was used. They concluded all hubs are potential sources of contamination and 
should be disinfected prior to use but that there was no significant difference between infections 
and bacteria colonization rates associated with the needleless connector and stopcock (Esteve et 
al., 2007). The findings from a clinical study conducted by Oto et al. (2007) also support that 
there is no increased risk of contamination from use of a stopcock versus a simple needleless hub 
when cleaned the same way prior to access.  
Potential Benefits of Stopcocks 
 These studies all touch on the concern that use of stopcocks increase infection risks and 
recommend against a continuous use of a stopcock within an IV tubing set. However, they do not 
address the use of stopcocks as a closed system for isolated lab collections in which the set of 
stopcocks is discarded after the sample is collected. A study conducted by Secola, Lewis, Pike, 
Needleman and Doering (2012) explored the possibility of developing a checklist for lab 
collections from central lines. Within this checklist a closed stopcock apparatus was included for 
collecting the blood sample (Secola et al., 2012). However, the rational behind the use of the 
stopcock is not included in this study. Within the discussion they reported that using a stopcock 
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may have been helpful but there was no evidence presented to support the use of the stopcock 
method for lab collections (Secola, et al., 2012). 
 Current evidence is insufficient for drawing a conclusion on the use of the stopcock 
method to make lab collections off of central lines more sterile and less invasive. However, the 
data to support minimizing number of times a central line is directly accessed during lab 
collection is substantial. In the blood collection checklist developed by Secola et al. (2012) the 
use of the stopcock method rather than multiple flushes to clear a cap was recommended as an 
effort to minimize the number of direct accesses on a central line. Guidelines from the CDC 
written by O'Grady et al. (2017) instruct providers to "minimize the number of manipulations of 
and entries into a system". Further research is needed in order to conclude if the isolated use of a 
set of stopcocks for collecting labs would assist in decreasing CLABSI rates.  
Agency Description 
Setting and Population 
 The agency in which the stopcock method for lab collections was implemented is a large, 
mid-western Children's Hospital. Riley Hospital for Children at Indiana University Health is a 
247-bed hospital comprised of 12 specialty units. Initially, the stopcock method for lab 
collections was implemented on the hematology/oncology unit (hemonc), which is a 26-bed unit. 
The hemonc unit is generally at full capacity with children admitted to acute care. The target 
population for lab collections using the stopcock method is pediatric patients with central venous 
lines in the hemonc area. Children in the target population typically range in ages from infants to 
18 year olds. There is no recruitment necessary with this target population as this is a practice 
change that is already implemented on the entire unit. Anyone with a central line will receive the 
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same standard care since the stopcock method is already in practice and is being reevaluated for 
efficacy.  
Congruence with Organizational Mission 
 An organization wide goal is to provide the best care possible to all patients. A way to 
contribute to accomplishing this goal is to decrease central line blood stream infection (CLABSI) 
rates. The Indiana University Health mission is "to improve the health of our patients and 
community through innovation, and excellence in care, education, research and service" (IU 
Health, 2017). The goal of using the stopcock apparatus to collect blood labs is to decrease the 
risk of contamination of central lines being accessed. If this innovative change in protocol was 
successful in decreasing contamination through minimizing accesses then CLABSI rates should 
decrease as well. The idea of making lab collections safer thus reducing patient harm events 
aligns with the mission of Indiana University Health. However, should this method not 
contribute to decreased CLABSI rates and in fact is a threat to patient safety it would not be in 
congruence with the organizational mission and its practice should be discontinued.  
Description of Stakeholders 
 Stakeholders within the organization are nursing staff, administrators, and patients. The 
goal for the stopcock method was to decrease CLABSI rates. Nursing staff is invested in this 
process change because it facilitates safer patient care and more time efficient lab collections. 
Hospital administration is invested in this process because decreasing central line infections 
helps to decrease unnecessary hospital costs and patient harm events, which negatively impact 
the hospital. The management implementing the process change plays a major role as 
stakeholders as it is important to have full managerial support during the implementation of a 
new practice change. The management also plays an integral role in the success of the practice 
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change through tasks such as ordering appropriate supplies and ensuring adequate staff training. 
Most importantly, the patients are the primary stakeholders for this process. Decreasing the risk 
of infection from central lines helps to increase patient safety and provide more effective care. 
Finally, there are stakeholders outside of the IU health organization. People such as outside 
educators, physicians, patient caregivers, researchers, and other patients could be stakeholders 
for this process. Success of this practice change would provide evidence to support the same 
practice change in other units or institutions.  
Site-specific Facilitators and Barriers  
 The most obvious barrier to the implementation of the stopcock is the current lack of 
research and data to support this method. The stopcock method does not have substantial 
supportive evidence in the literature. Another barrier prior to implementation of this practice 
change was the fact that this method was new, requiring education for the healthcare providers. 
Anytime a practice change is implemented staff "buy in" or support is a barrier that has to be 
considered. Nursing staff is the most critical group to consider for promoting "buy in" for any 
practice change implementation. Ensuring that the nursing staff supports a practice change is 
imperative to its success. There are also a few facilitators to this protocol implementation. The 
first is any stakeholder that is positive and supportive of the practice change. Another important 
facilitator for this practice change could be a nurse champion from St Louis Children's Hospital 
as it is already successfully implemented on the hemonc unit at this facility with positive impacts 
on reduction of CLABSI rates.  
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Project Designs and Methods 
Description of Intervention  
  Limited data supporting the stopcock method for lab collection exists in literature. The 
lack of evidence, recognition of the potential benefits of the employment of stopcocks for lab 
collection, and continued problematic CLABSI rates initiated the completion of a retrospective 
data review spanning over a ten-year period. This data review began with meeting the clinical 
nurse specialist specific to the hemonc unit. At this meeting a plan was developed to compile and 
review data for the pre/post intervention time frame in order to evaluated the impact of the 
intervention. The data used for evaluation was obtained from the infection prevention team at the 
facility. This team is responsible for tracking monthly infection rates. The support of the facility 
was obtained through the Chief Nursing Officer by presenting the goal and potential benefits of 
this data review. Finally, an IRB application for exemption was developed and submitted.  
 The clinical components of the use of stopcocks for lab collections from central lines 
involved the assembly of two stopcocks, 2 20mL normal saline flushes, and 1 10mL empty 
syringe. The use of two stopcocks provides four open ports. The first port is attached to the 
patient, the second is used for an initial flush of the line and to collection back waste, the third 
port is used to collect the lab sample, and the forth port is used for the final flush. The apparatus 
is assembled together to allow the healthcare provider to clean and access the central line one 
time for all steps of a lab collection. The entire lab collection process can be preformed after 
thorough sterilization of hub through this one connection as described in appendix A. 
IRB Approval  
 Approval for the evaluation project was obtained from The University of Kentucky 
Office of Research Integrity. Riley Hospital for Children did not require prior approval, as this is 
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a process that is already in practice in the hospital. Data collected was preexisting and did not 
contain any patient specific information or identifiers. The project was a unit based practice-
improvement evaluation. A letter of support was obtained from Riley Hospital for Children's 
Chief Nursing Officer, Elizabeth Linden.  
Sample 
 The sample included 12 months of data for 10 years of infection rates. This data was 
collapsed into yearly rates due to months with a 0 infection rates and for the sake of analysis. 
Yearly comparison makes the data standardized & conducive to pre/post comparison. The 
CLABSI rates were recorded monthly by the infection prevention team for the facility. The 
sample for this study was taken from the data recorded for the hemonc unit. The infection rates 
were recorded for the unit and no patient identifiers were included in this record. The typical 
population for this unit is aged 18-years-old an under. The hemonc unit is comprised of two 
wings. Patients are admitted to a wing within the unit based on diagnosis and infection risk. 
There was no exclusion of data collected, as all monthly reports for the hemonc unit were 
included for data analysis. The data that comprised the pre-intervention group came from a 
CLABSI rates from 2008-2012. Data comprising the post-intervention group came from 
CLABSI rates from 2013-2018. Collecting the data was done via a spreadsheet with permission 
from the Chief Nursing Officer and assistance of the hematology/oncology clinical nurse 
specialist at Riley Hospital for Children 
Data Analysis and Measures 
 The practice change evaluation for the use of the stopcock method is a retrospective 
pre/post intervention design. This data review is to evaluate the effectiveness of the current 
practice related to lab collection via central lines. The data analysis involved comparing 
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infections rates prior to implementation of the stopcock method to infection rates collected after 
its implementation. The timeline of the implementation of the stopcock method was also 
analyzed to provide context for the CLABSI rate changes after practice change implementation. 
 Frequency of CLABSI rates were analyzed in a table of infection rates for the years 
classified as pre-implementation and compared to the years classified as post-implementation 
(Table 1). In order to make this comparison more clear graphs were developed using this data 
(Table 2/3). Consistency in comparison is important to decrease limitations and control 
confounders. Therefore, data from the same unit with the same patient population before and 
after the intervention was compared. The CLABSI rates are in a comparable form through a 
standard method for calculating the rates. In order to get the rate the total number of infections 
was divided by the total number of lines and multiplied by 1000. This calculation provides 
CLABSI rates per 1000 line days, which allows the rates to be compared and analyzed. The 
patient population included any pediatric patient admitted to the hemonc unit who had a central 
line device Patients admitted to these units are typically between infancy and 18 years old. This 
unit is typically at capacity and has a high number of patients with central lines.  
 Implementation 
 The education of staff prior to this practice change reportedly took place in 2013. The 
specifics of the staff education process are unknown. This study is a retrospective data review in 
order to evaluate the effectiveness of the current practice. The current practice was implemented 
prior to this data review. Data collection began with meetings between the hemonc manager, 
hemonc clinical nurse specialist, and primary investigator. The primary investigator and clinical 
nurse specialist began compiling monthly CLABSI rates from recorded data on an excel 
spreadsheet. The monthly data rates were collapsed into yearly rates and graphs were made to 
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clearly depict the pre/post results. Preforming a pre/post statistical test was not reasonable due to 
other findings uncovered during this data review. The final report is based on the analysis of data 
comparing infection rates from before and after the initial practice implementation. This data 
analysis provides a pre/post comparison of the use of stopcocks for lab collections to determine 
if they successfully helped reduce central line infection rates over the past several years.  
Timeline, Resources, and Feasibility 
Timeline 
 The timeline for this project started with meetings with the hemonc clinical nurse 
specialist is Junary 2019. The primary data collection and evaluation occured from May 2019 
through October 2019. The project application was submitted to the Office of Research Integrity 
at The University of Kentucky by the end of May 2019 and approved in September 2019. The 
clinical nurse specialist for the hemonc unit at Riley Hospital for Children assisted in data 
collection. The data for infection rates was collected for the pre (2008-2012) and post (2013-
2018) data. During the month of October the information was complied and studied for 
frequency of CLABSI occurrences and comparisons. The preliminary findings were shared in 
October with the clinical nurse specialist and manager for the hemonc unit.  
Sustainability 
 The sustainability of this process is dependent on the findings of the data comparison. 
The goal of the stopcock method use for lab collections from central lines is to decrease CLABSI 
rates. If the infection rates actually increase over time then this method of lab collections should 
be evaluated and possibly discontinued. If current infection rates continue, the practice method 
should revised and reevaluated in order to draw an evidence-based conclusion. If the infection 
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rates decline, the practice change should continue on this unit, be trialed and implemented 
through other areas of the hospital, and possibly through the entire hospital system. 
Results 
 The data collected revealed varying rates of central line associated blood stream 
infections for both pre and post intervention results (Table 2). The stopcock method was 
implemented in 2013 during which time the overall CLABSI rates show a slight drop in recorded 
infections for the hematology/oncology unit as a whole (Table 3). Since the implementation of 
the stopcock method the unit totals have fluctuated staying within a range of 35.7 to 52.9 (Table 
3). The CLABSI rates were tracked in further detail based on the area of the unit, which 
differentiates the typical patient population in each area. The area of the unit called 5EA is often 
specific to the transplant population and 5W is the rest of the hematology/oncology population. 
The overall CLABSI rates are tracked for each area along with the CLABSI rates that do not 
include a specific line infection classified as a mucosal barrier injury–associated, laboratory-
confirmed bloodstream infection (MBI-LCBI) (Torres et al., 2016). The oncology population 
typically has a higher rate of infections classified as MBI-LCBI (Torres et al., 2016).  These 
infections are not reported out as CLABSI by Riley Hospital for Children but are important to 
account for. The total infection rates separated by the two patient population units are shown in 
Table 2 as bar graphs while the CLABSI rates excluding MBI-LCBI rates are plotted as a line. 
The data does not clearly depict the impact of the stopcock method. After implementation the 
rates continue to fluctuate and there is no clear trend down in infection rates. The infection rates 
prior to the initiation of stopcocks ranges from 26.7-41 with an average of 31.4 for the 5 pre-
years assessed. The infection rates after the initiation of the stopcock range from 35.7-52.9 with 
an average of 43.2 for the 6 post-years assessed. The rates are all reported per 1000 line days. 
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Based on the data the average infection rate before the initiation of the stopcock method was 
lower than the average infection rate after the stopcock method practice began. Due to 
confounding variables during the initial implementation of the stopcock method preforming a 
statistical pre/post analysis test does not provide reliable results.   
Discussion 
 The data reveals slight differences in the infection rates between the two divisions of the 
unit but these findings are not conclusive. This difference is likely partially attributed to the 
difference in the two primary patient populations that the hematology/oncology service cares for. 
The 5EA side of the unit is often specific to the transplant population. This patient population is 
typically at a higher risk than 5W due to their length of stay and how prolonged their immune 
systems are suppressed. However, the 5EA side also has a relatively consistent renal population. 
The renal patients only intermittently contribute to the line data, which contributes to the slightly 
lower rate than the 5W side of the unit. The 5W side of the unit consists of the rest of 
hematology/oncology population. This side of the unit accommodates patients receiving 
chemotherapy, being admitted for fever management, and the hematology population. The 
hematology population on the 5W side would typically include patients such as those in sickle 
cell crisis or with hemophilia. Based on this patient population the 5W side of the 
hematology/oncology unit generally has more patients with central lines that are frequently 
accessed for lab collections and/or therapies. This more frequent line use could be a factor in the 
higher rate of infections for this side of the unit. 
 The overall trend of the data does not allow for a clear conclusion to be drawn about the 
relationship between the use of the stopcock method for lab collections and infection rates. 
Based on this data it appears as though the stopcock method does not decrease infection rates. 
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The average infection rate of the post intervention data is higher than the average infection rate 
for the pre intervention data. Therefor, at this time, it cannot be said that the stopcock method for 
lab collections helps decrease CLABSI rates.  
 As a result of the findings of this study a standardized protocol is in the process of 
development as a result of this data review and will be implemented in order to ensure proper 
practice of the stopcock method in the future. The re-education for the hemonc unit with the new 
protocol will take place for a month, ensuring adequate opportunity for training on all shifts. The 
first task will be educating the staff members who will serve as change champions. The lead 
investigator, the manager of the hemonc unit, and the clinical nurse specialist of the hemonc unit 
will be responsible for providing education to the change champions. These nurses will be 
provided education by the line team and will check off prior to beginning education sessions on 
the unit. After the change champions have demonstrated competency, the protocol will be 
distributed around the unit for review. The unit will be informed as to who the change champions 
are and will be directed to approach them or leadership with questions. It is imperative that the 
change champions promote positivity and demonstrate confidence in their skills when 
implementing the protocol, as change champions can be imperative to the success of a practice 
change in the hospital setting (Shaw et al., 2013). Following the distribution of the new protocol 
staff will be provided education through hands-on practice facilitated by the change champions 
or unit leadership as the facilitator. Finally, all staff will be required to complete a check-off. 
These check-offs will be initiated by the registered nurse working in the unit during a shift and 
may be in the presence of one of the change champions or a member of management. The check 
off will require the nurse to be responsible for completing the task of collecting a lab from a 
central line on a manikin without breaking sterile technique. Every nurse will also be observed 
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by a change champion, lead investigator, the manager of the hemonc unit, or the clinical nurse 
specialist of the hemonc unit when completing the task for the first time with a patient.   
 The new standardized protocol will be implemented after adequate training and 
education. The protocol will be finalized after decisions are made on the appropriate 
requirements for sterility of the stopcock lab collection process. There will be a deadline for 
completing the education and check off. The hemonc management will issue corrective actions 
for any nurse that does not meet the deadline as proper education is imperative to the success of 
the current practice and to the safety of the patients. 
Limitations 
 There are several limitations to this study. The data shows a spike in infections in 2012. 
This spike led to multiple changes in order to decrease infection rates. Initiating multiple changes 
simultaneously makes it impossible to distinguish the cause and effect of outcomes. The fact that 
the stock method was not trialed in an isolated fashion is the first limitation as there is no way to 
truly know the impact it had on infection rates. The other limitations to be acknowledged include 
but are not limited to discontinuation of biopatch device, introduction of chlorhexidine-gluconate 
cleanse, changes in needleless cap care protocols, discrepancies in the most appropriate approach 
for stopcock apparatus assembly, and lack of a true practice protocol for the stopcock lab 
collection.   
Biopatch 
 The hospital discontinued use of a device called a biopatch at the end of 2013. A study by 
Safdar et al. (2014) describes a biopatch as "a round chlorhexidine-impregnated sponge 
dressing which is placed circumferentially around the insertion site". This study concluded 
that chlorhexidine-impregnated dressings help to prevent infections (Safdar et al., 2014). 
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However, the used of these patches were discontinued around the same time that the stopcock 
method was initiated. The justification for the discontinuation of the biopatch use is unclear.  
Chlorhexidine-gluconate Cleanse 
 Chlorhexidine-gluconate (CHG) is an antimicrobial agent used on the skin to reduce 
bacteria that can lead to infection (Food and Drug Administration, 2017). Riley Hospital for 
Children initiated daily CHG cleansing for patients with central lines at the end of 2012. There 
are conflicting reports regarding CHG cleansing and the impact it has on CLABSI rates. A study 
by Popovich, Hota, Hayes, Weinstein, & Hayden (2010) concluded that CHG had no impact on 
CLABSI rates while a study by Montecalvo et al. (2012) found significant reductions in CLABSI 
rates with CHG bathing. The initiation of CHG cleansing happened around the same time as the 
stopcock method. The simultaneous initiation of different interventions to combat CLABSI rates 
limits the ability to determine causal relationships between variables.    
Needleless Cap Maintenance  
 At the end of 2012 Riley Hospital for Children also changed the protocols for needleless 
access device maintenance. Needleless access device sit at the end of the line allowing 
connections to the line to be made between two luer lock ends. The hospital changed the policy 
regarding changing these devices. The new protocol required needleless access devices to be 
changed every 96 hours and did not require removal prior to blood cultures. This is another 
example of multiple changes being initiated at the same time making it difficult to determine the 
impact the stopcock lab collection method had on CLABSI rates.  
Stopcock Apparatus Assembly  
  The clinical nurse specialist is evaluating the set up of the stopcock apparatus to 
determine best practice for this task. The question is in regards to the sterility required while 
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setting up this system. Currently, the practice is to set up the apparatus using aseptic technique. 
However, initially the stopcock apparatus is an open system until it is assembled. As an open 
system the set up should require sterile technique. There is limited research regarding stopcock 
use for lab collections and the most appropriate way to execute this practice. However, research 
shows that anytime a central line is classified as "open" or requires intervention that increases 
susceptibility to infection sterile technique should be implemented (Ling et al., 2016). This 
serves as another significant limitation as the stopcock apparatus has always been set up using 
aseptic technique.  
Practice Protocol  
 The final limitation to be addressed is the lack of a protocol associated with this practice. 
The stopcock lab collection method on the hematology/oncology unit was in practice prior to 
employment of any of the current leadership. This practice was initiated in 2013 with an 
unknown education and without any true protocol in place. Since its initiation a "critical 
elements" guide has been in use but no protocol has been developed.  The lack of a true protocol 
to follow makes it impossible to know if the execution by staff was appropriate.  
Future Implications  
 There are several implications elicited from this research. The evaluation of the use of the 
stopcock method for lab collections uncovered several process improvement needs. Most 
importantly, the research uncovered the need for a true standardized protocol for lab collections 
using this method, which is currently in the process of being created (appendix A). Furthermore, 
the need for reeducation of the staff executing this practice procedure will be required once the 
practice protocol is established. This protocol will be initiated after the question of sterility is 
resolved. This protocol should be initiated after reeducation for the staff and competency check-
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offs to ensure best practice is followed. After the unit has initiated a true protocol this research 
should be repeated. This research is inconclusive due to the fact that there were multiple 
limitations and cofounding variables involved. Ideally, the research should be repeated when it is 
an isolated intervention being evaluated. The pre and post infection rates should be tracked over 
a period of time in order to compare rates and evaluate the effectiveness of the use of stopcocks 
for lab collections.  
Summary/Conclusion 
 Central line associated blood stream infections are dangerous consequences of medical 
treatments that can be prevented. These infections are not only costly in a monetary aspect but 
are also life threatening (Center for Disease Control and Prevention, 2016). The stopcock method 
has the potential to decrease risk of infections through the use of an apparatus that prevents 
multiple accesses to a patient's central line. The decrease in number of times a line is accessed 
inadvertently decreases the risk of introducing infection. This research study cannot definitively 
draw conclusions on the relationship between the stopcock method and CLABSI rates due to the 
multiple limitations and confounding variables impacting the findings. The use of stopcocks for 
lab collections should be evaluated further in order to determine best practice recommendations 
for collecting labs from central lines.  
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Figure 1: Stopcock Apparatus  
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Figure 2: The Adoption Process  
(A	  Conceptual	  Framework)	  
	  
(Botha, N., & Atkins, K., 2005)	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Appendix A: Stopcock Method Intervention 
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Table 1: Overall CLABSI Rates per 1000 Line Days 
Year	   Pre-­‐stopcock	  Infection	  Rates	  
2008	   31.4	  
2009	   29.9	  
2010	   28	  
2011	   26.7	  
2012	   41	  
Year	   Post-­‐stopcock	  Infection	  Rates	  
2013	   39.5	  
2014	   42.9	  
2015	   41.5	  
2016	   52.9	  
2017	   46.5	  
2018	   35.7	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Table 2: Unit Total CLABSI Rates 
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Table 3: Hematology/Oncology CLABSI Rates by Area 
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Table 4: Hematology/Oncology CLABSI Rates by Area 
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